Navellier & Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Buy
69,038
+2,889
+4% +$600K 1.3% 13
2026
Q1
$14M Buy
66,149
+2,381
+4% +$513K 1.46% 15
2025
Q4
$13.1M Buy
+63,768
New +$12M 1.47% 13
2021
Q2
Sell
-5,425
Closed -$330K 304
2021
Q1
$330K Sell
5,425
-665
-11% -$36.7K 0.06% 224
2020
Q4
$326K Buy
+6,090
New +$316K 0.06% 211

Other funds holding CAH

Navellier & Associates's CAH Position: Q2 2026 in Review

Navellier & Associates increased its Cardinal Health (CAH) stake by 4.4% in Q2 2026, buying an estimated $600K and bringing the position to 69,038 shares worth $16.4M. The position accounts for 1.3% of the portfolio, ranked #13.

Navellier & Associates first reported a position in CAH in Q4 2020 and has held it in 5 quarters since. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Navellier & Associates held 69,038 shares of Cardinal Health worth $16.4M as of Q2 2026.
  • Navellier & Associates bought 2,889 Cardinal Health shares in Q2 2026, an estimated $600K.
  • Cardinal Health made up 1.3% of Navellier & Associates's portfolio in Q2 2026, its #13 holding.
  • Navellier & Associates first reported a position in Cardinal Health in Q4 2020 and has held it in 5 quarters since.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.